Aaron WEI MING Seah

Dr. Aaron WEI MING Seah

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Open access
ISIsaac Seow-En
Isaac Seow-En
JWJingting Mbbs Wu
Jingting Mbbs Wu
ITIvan En-Howe Mba Tan
Ivan En-Howe Mba Tan
YZYun Zhao
Yun Zhao
ASAaron WEI MING Seah
Aaron WEI MING Seah
ETEmile Mbbs Kwong-Wei Tan
Emile Mbbs Kwong-Wei Tan
Introduction: Total mesorectal excision (TME) with delayed coloanal anastomosis (DCAA) is surgical option for low rectal cancer, replacing conventional immediate coloanal anastomosis (ICAA) with bowel diversion. This study aimed to assess the outcomes of transanal TME (TaTME) with DCAA versus laparoscopic TME (LTME) with ICAA versus robotic TME (RTME) with ICAA. Methods: This was a retrospective propensity score-matched analysis of patients who underwent elective TaTME-DCAA between November 2021 and June 2022. Patients were propensity-score matched in a ratio of 1:3 to patients who underwent LTME-ICAA and RTME-ICAA from January 2019 to December 2020. Outcome measures were histopathologic results, postoperative morbidity, function, and inpatient costs. Results: Twelve patients in the TaTME-DCAA group were compared with 36 patients in the LTME-ICAA and RTME-ICAA groups each after propensity score matching. Histopathologic results and postoperative morbidity rates were statistically similar. Overall stoma-related complication rates in the ICAA groups were 11%. Median total length of hospital stays for TME plus stoma reversal surgery was similar across all techniques (10 vs. 10 vs. 9 days; P=0.532). Despite a significantly shorter duration of follow-up, bowel function after TaTME-DCAA was comparable to that of LTME-ICAA and RTME-ICAA. Overall median inpatient costs of TaTME-DCAA were comparable to LTME-ICAA and significantly cheaper than RTME-ICAA ($31,087 vs. $29,927 vs. $36,750; P=0.002). Conclusions: TaTME with DCAA is a feasible and safe technique compared with other minimally invasive methods of TME, while avoiding bowel diversion and stoma-related complications, as well as comparing favorably in terms of overall hospitalization costs.

14 August 2024 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
ISIsaac Seow-En
Isaac Seow-En
MVMaureen Elvira Villanueva
Maureen Elvira Villanueva
ASAaron WEI MING Seah
Aaron WEI MING Seah
ETEmile John Kwong Wei Tan
Emile John Kwong Wei Tan
JAJoella Xiaohong Ang
Joella Xiaohong Ang

30 June 2026 in Annals of Coloproctology
Verified
Journal Article
Open access
ASAaron WEI MING Seah
Aaron WEI MING Seah
ISIsaac Seow-En
Isaac Seow-En
KHKoo Chee Hoe
Koo Chee Hoe
LCLionel Raphael Hui Chen
Lionel Raphael Hui Chen
YRYvonne Ng Ying Ru
Yvonne Ng Ying Ru
ETEmile Kwong Wei Tan
Emile Kwong Wei Tan
Purpose: Robotic and laparoscopic approaches to rectal cancer surgery yield comparable short-term outcomes; however, comparative inpatient costs, particularly when stratified by tumor level, remain insufficiently characterized. This study compared short-term clinical and pathological outcomes, as well as index hospitalization costs, for minimally invasive surgery in patients with mid and low rectal cancer.Methods: All consecutive patients with mid (5–10 cm from the anal verge) and low (<5 cm from the anal verge) rectal cancer who underwent elective minimally invasive surgery between January 2018 and December 2023 were identified. One-to-one propensity score matching was performed using the following covariates: age, sex, body mass index, American Society of Anesthesiologists physical status, tumor level, receipt of neoadjuvant therapy, and presence of a defunctioning stoma. Outcomes and cost components were compared overall and stratified by tumor level.Results: After matching, 282 patients were included (laparoscopic surgery, n=141; robotic surgery, n=141). Median operative time was longer in the robotic group (368 minutes vs. 325 minutes, P=0.007), whereas the median postoperative length of stay was similar between groups (6.0 days vs. 6.0 days, P=0.255). Rates of conversion to open surgery, anastomotic leak, 30-day mortality, and 30-day readmission did not differ significantly. Histopathological indicators of resection quality, including lymph node yield, margin clearance, and completeness of total mesorectal excision, were comparable. Mean index hospitalization cost was higher in the robotic group (SGD 37,436 vs. SGD 31,724; difference, SGD 5,713; P=0.008), with a greater difference observed in mid rectal cancer (SGD 8,606; P=0.008) than in low rectal cancer (SGD 1,811; P=0.465).Conclusion: Robotic and laparoscopic surgery yielded comparable short-term clinical and pathological outcomes. Although costs were higher with robotic surgery, the cost differential was smaller for low rectal cancer, identifying this subgroup as a priority for prospective evaluation of clinical and economic value.

7 October 2026 in Cancers
Verified
Journal Article
Open access
PDF file
LCLionel Raphael Hui Chen
Lionel Raphael Hui Chen
IWIan Wee
Ian Wee
JTJun Kiat Thaddaeus Tan
Jun Kiat Thaddaeus Tan
ASAaron WEI MING Seah
Aaron WEI MING Seah
ASAnders Jacobsen Skanderup
Anders Jacobsen Skanderup
BTBee Huat Iain Tan
Bee Huat Iain Tan
Background: Early-onset colorectal cancer (EOCRC, diagnosed <50 years) is increasing globally and presents with advanced clinicopathological features, yet its mutational landscape compared to late-onset CRC (LOCRC) remains poorly defined. Methods: We systematically searched PubMed and Embase (January 2016–December 2025) for studies comparing somatic mutations between EOCRC and LOCRC. Two reviewers independently screened 1880 records; 43 studies met inclusion criteria. Two public datasets (TCGA, China PanCancer) were also included. Meta-analyses were conducted using random-effects models with Review Manager. Subgroup analysis was restricted to microsatellite-stable (MSS) tumors. Meta-regression evaluated study-level differences in tumor sidedness and stage distribution as sources of heterogeneity. The primary outcome was odds ratios (OR) for mutations in 10 driver genes. Results: Among 154,982 participants, 33,937 (21.9%) had EOCRC. In the overall analysis, EOCRC showed higher frequencies of TP53 (OR 1.13), SMAD4 (OR 1.15), and PTEN mutations (OR 1.77), and lower frequencies of APC (OR 0.73), KRAS (OR 0.94), and BRAF mutations (OR 0.69). In MSS-restricted analysis, differences persisted for TP53, SMAD4, APC, and KRAS, whereas PTEN and BRAF differences became non-significant. Additionally, NRAS (OR 0.74) and PIK3CA mutations (OR 0.89) were less frequent in MSS-EOCRC. Meta-regression showed that study-level differences in left-sided tumor distribution were associated with lower relative BRAF mutation frequency in EOCRC (β = −5.08, 95% CI −7.66 to −2.49, p < 0.001). Conclusions: EOCRC exhibits a different mutational profile with higher TP53 and SMAD4 and lower APC and KRAS mutations. These findings highlight the need for further research into alternative mechanisms of CRC carcinogenesis among younger adults.